Abstract
In congenital adrenal hyperplasia (CAR) due to 21-hydroxylase deficiency, measurement of plasma renin activity (PRA) has been the method of choice in diagnosing salt loss and in monitoring adequacy of mineralocorticoid replacement therapy. Due to methodological problems in PRA determinations, direct immunoradiometric assays for the measurement of active renin concentration have been developed. We measured PRA and active renin concentrations simultaneously in 39 patients with CAH (30 salt-wasting, 9 simple virilizing) to evaluate the potential role of this new method in the management of this disease. PRA was determined with an enzymatic assay (sample volume: 2 × 1000 μl plasma), active renin concentration with a direct immunoradiometric assay (sample volume: 2 × 200 μl plasma or serum). We found a highly significant correlation between active renin and PRA in our patients (P < 0.001), as previously shown in healthy subjects. Active renin was as reliable as PRA to assess the quality of mineralocorticoid replacement.
Similar content being viewed by others
Abbreviations
- CAH :
-
congenital adrenal hyperplasia
- PRA :
-
plasma renin activity
- SV :
-
simple-virilizing
- SW :
-
salt-wasting
References
Asbert M, Jiménez W, Gaya J, Ginés P, Arroyo V, Rivera F, Rodés J (1992) Assessment of the renin-angiotensin system in cirrhotic patients. Comparison between plasma renin activity and direct measurement of immunoreactive renin. J Hepatol 15: 179–183
Bangham DR, Robertson I, Robertson JIS, Robinson CJ, Tree M (1975) An international collaborative study of renin assay: establishment of the international reference preparation of human renin. Clin Sci Mol Med 48 [Suppl 2]: 135s-159s
Blazy I, Guillot F, Laborde K, Dechaux M (1989) Comparison of plasma renin and prorenin in healthy infants and children as determined with an enzymatic method and a new direct immunoradiometric assay. Scand J Clin Lab Invest 49: 413–418
Derkx FHM, Stuenkel C, Schalekamp MPA, Visser W, Huisveld IH, Schalekamp MADH (1986) Immunoreactive renin, prorenin, and enzymatically active renin in plasma during pregnancy and in women taking oral contraceptives. J Clin Endocrinol Metab 63:1008–1015
Dessi-Fulgheri P, Cocco F, Glorioso N, Bandiera F, Madeddu P, Rappelli A (1987) Immunoradiometric assay of active renin in human plasma: comparison with plasma renin activity. Clin Exp Hypertens [A] A9 (8, 9): 1383–1390
Dillon MJ, Ryness JM (1975) Plasma renin activity and aldosterone concentration in children. BMJ 4: 316–319
Dillon MJ, Gillin ME, Ryness JM, Swiet M de (1976) Plasma renin activity and aldosterone concentration in the human newborn. Arch Dis Child 51: 537–540
Fiselier TJW, Lijnen P, Monnens L, Munster P van, Jansen M, Peer P (1983) Levels of renin, angiotensin I and II, angiotensin converting enzyme and aldosterone in infancy and childhood. Eur J Pediatr 141: 3–7
Fischer TJW, Derkx F, Monnens L, Munster P van, Peer P, Schalekamp M (1984) The basal levels of active and inactive plasma renin concentration in infancy and childhood. Clin Sci 67: 383–387
Galen FX, Devaux C, Atlas S, Guyenne T, Menard J, Corvol P (1984) New monoclonal antibodies directed against human renin. Powerful tools for the investigation of the renin system. J Clin Invest 74: 723–735
Griffiths KD, Anderson JM, Rudd BT, Virdi NK, Holder G, Rayner PHW (1984) Plasma renin activity in the management of congenital adrenal hyperplasia. Arch Dis Child 59: 360–365
Holcombe JH, Keenan BS, Clayton GW, Kumar S (1981) Plasma 17α-hydroxyprogesterone and aldosterone concentrations in infants and children with congenital adrenal hyperplasia - the role of salt-losing hormones in salt wasting. J Pediatr 98: 573–575
Homer JM, Hintz RL, Luetscher JA (1979) The role of renin and angiotensin in salt-losing, 21-hydroxylasedeficient congenital adrenal hyperplasia. J Clin Endocrinol Metab 48: 776–783
Hsueh WA, Baxter JD (1991) Human prorenin. Hypertension 17: 469–479
Knorr D (1985) Das congenitale adrenogenitale Syndrom. Monatsschr Kinderheilkd 133: 327–335
Kuhnle U, Rösler A, Pareira JA, Gunzcler P, Levine LS, New MI (1983) The effects of long-term normalization of sodium balance on linear growth in disorders with aldosterone deficiency. Acta Endocrinol 102: 577–582
Limal JM, Rappaport R, Bayard F (1977) Plasma aldosterone, renin activity and 17-hydroxyprogesterone in salt-losing congenital adrenal hyperplasia. Response to ACTH in hydrocortisone treated patients and effect of 9-fluorocortisol. J Clin Endocrinol Metab 45: 551–559
Lutterotti N von, Catanzaro DF, Sealey JE, Laragh JH (1994) Renin is not synthesized by cardiac and extrarenal vascular tissues. A review of experimental evidence. Circulation 89: 458–470
Mellon SH, Miller WL (1989) Extraadrenal steroid 21-hydroxylation is not mediated by P450c21. J Clin Invest 84: 1497–1502
Menard J, Guyenne T-T, Corvol P, Pau B, Simon D, Roncucci R (1985) Direct immunometric assay of active renin in human plasma. J Hypertens 3[Suppl 3]: 8275–8278
Miller WL (1994) Clinical Review 54: genetics, diagnosis, and management of 21-hydroxylase deficiency. J Clin Endocrinol Metab 78: 241–246
New MI (1995) Steroid 21-hydroxylase deficiency (Congenital adrenal hyperplasia). Am J Med 98[Suppl 1A]2S-8S
Nicar MJ (1992) Specimen processing and renin activity in plasma. Clin Chem 38: 598
Ohyama K, Ohta M, Fujimoto M, Nakagomi Y, Yamori T, Kato K (1989) Plasma active renin concentration in children. Endocrinol Jpn 36: 605–610
Plouin PF, Cudek P, Arnal JF, Guyenne T-T, Corvol P (1990) Immunoradiometric assay of active renin versus determination of plasma renin activity in the clinical investigation of hypertension, congestive heart failure, and liver cirrhosis. Horm Res 34: 138–141
Rösler A, Levine LS, Schneider B, Novogroder M, New MI (1977) The interrelationship of sodium balance, plasma renin activity on ACTH in congenital adrenal hyperplasia. J Clin Endocrinol Metab 45: 500–512
Schaison G, Couzinet B, Gourmelen M, Elkik F, Bougneres P (1980) Angiotensin and adrenal steroidogenesis: study of 21-hydroxylase-deficient congenital adrenal hyperplasia. J Clin Endocrinol Metab 51: 1390–1394
Sealey JE (1991) Plasma renin activity and plasma prorenin assays. Clin Chem 37:1811–1819
Simon D, Hartmann DJ, Badouaille G, Calliot G, Guyenne T-T, Corvol P, Pau B, Marchand J (1992) Two-site direct immunoassay specific for active renin. Clin Chem 38: 1959–1962
Speiser PW, Agdere L, Ueshiba H, White PC, New MI (1991) Aldosterone synthesis in salt-wasting congenital adrenal hyperplasia with complete abscence of adrenal 21-hydroxylase. N Engl J Med 324: 145–149
White PC, New MI, Dupont B (1987) Congenital adrenal hyperplasia (Two parts). N Engl J Med 316: 1519–1524; 1580–1586
Zuo WM, Pratt RE, Heusser CH, Bews JPA, Gasparo MM de, Dzau VJ (1992) Characterization of a monoclonal antibody specific for human active renin. Hypertension 19: 249–254
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Krüger, C., Höper, K., Weissörtel, R. et al. Value of direct measurement of active renin concentrations in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Eur J Pediatr 155, 858–861 (1996). https://doi.org/10.1007/BF02282834
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02282834